A Study of Fosmanogepix in Participants With Invasive Mold Infections
A Study of Fosmanogepix in Participants With Invasive Mold Infections. A Phase 2, Open-Label Study to Evaluate the Safety and Efficacy of APX001 in the Treatment of Patients With Invasive Mold Infections Caused by Aspergillus Species or Rare Molds.
Category & Conditions: Infections and Infectious Diseases
Medicine: Fosmanogepix (PF-07842805)
ClinicalTrials.gov Identifier (NCT): NCT04240886
Protocol ID: C4791010 (APX001-202)
PrintDownloadOpen Plain Language Summary Result: Click here